AstaReal AB, part of the AstaReal Group, a fully owned subsidiary of the Japanese pharmaceutical company Fuji Chemical Industries Co., Ltd., has introduced its astaxanthin brand NOVASTA® in the European market. With its high content of natural astaxanthin and additional valuable carotenoids, proteins, carbohydrates and essential fatty acids, the ingredient supports optimal health and nutrition for a variety of animals.

Astaxanthin is nature’s most powerful antioxidant. Derived from the microalgae species Haematococcus pluvialis, science has proven that it has wide-ranging benefits for muscles, eyes, the brain, immune system and much more. As it is suitable for all animals, including pets and those in competitive sport, agriculture and aquaculture, the market opportunities for NOVASTA® are vast. 

Microalgae-derived astaxanthin represents a sustainable and naturally sourced feed ingredient with excellent eco credentials. NOVASTA® ensures optimal growth, health and pigmentation in fish and crustaceans. It also allows aquaculturists to use fewer fish-based products, as it is derived wholly from algae, which means close-to-nature nutrition as well as environmentally sound aquaculture. 

AstaReal AB has distinguished roots, spinning off from Uppsala University in Sweden. In the early 1990s, the company established its first production facility in Gustavsberg, Sweden. In 1995, AstaReal launched Astaxin – the first human nutritional supplement containing a natural source of astaxanthin. AstaReal is Kosher, Halal, ISO 9001:2008 and HACCP certified and produces natural astaxanthin at facilities in Sweden, USA and Japan.